Adamcapital Gestao De Recursos Ltda. Abb Vie Inc. Transaction History

Adamcapital Gestao De Recursos Ltda.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $32.2 Million - $37.9 Million	-417,073 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $3.77 Million - $4.65 Million	48,451 Added 13.14%	417,073 $38.5 Million
Q3 2018 Oct 22, 2018	SELL	$88.91 - $98.84 $2.69 Million - $2.99 Million	-30,205 Reduced 7.57%	368,622 $34.9 Million
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $12.4 Million - $14.7 Million	-138,386 Reduced 25.76%	398,827 $37 Million
Q1 2018 Apr 13, 2018	BUY	$92.01 - $123.21 $21.2 Million - $28.3 Million	230,060 Added 74.9%	537,213 $50.8 Million
Q4 2017 Feb 22, 2018	BUY	$89.56 - $98.21 $27.5 Million - $30.2 Million	307,153	307,153 $29.7 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Adamcapital Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

Stay updated on Adamcapital Gestao De Recursos Ltda. with notifications on news.